TC Medical(SH:600763) Sou Hu Cai Jing·2026-02-04 12:01Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Tongce Medical (600763), indicating a slight increase in stock price and a mixed flow of funds on February 4, 2026 [1][2] - As of February 4, 2026, Tongce Medical's stock closed at 48.84 yuan, up 1.2%, with a turnover rate of 3.11% and a trading volume of 139,300 hands, amounting to a total transaction value of 675 million yuan [1] - The fund flow data shows a net outflow of 30.88 million yuan from main funds, accounting for 4.57% of the total transaction value, while retail investors saw a net inflow of 42.81 million yuan, representing 6.34% of the total transaction value [1] Group 2 - In the third quarter of 2025, Tongce Medical reported a main revenue of 2.29 billion yuan, a year-on-year increase of 2.56%, and a net profit attributable to shareholders of 514 million yuan, up 3.16% year-on-year [2] - The company's third-quarter performance included a single-quarter main revenue of 842 million yuan, reflecting a 2.34% year-on-year increase, and a net profit of 192 million yuan, which is a 2.31% increase year-on-year [2] - The company has a debt ratio of 25.1%, with investment income of 41.22 million yuan and financial expenses of 31.93 million yuan, while maintaining a gross profit margin of 41.69% [2]